Oh Won Sup, Chon Sung-Bin
Department of Internal Medicine, Kangwon National University School of Medicine, Chuncheon, Korea .
Department of Emergency Medicine, Seoul National University College of Medicine, Seoul, Korea .
J Korean Med Sci. 2016 May;31(5):814-6. doi: 10.3346/jkms.2016.31.5.814. Epub 2016 Mar 11.
Fluid resuscitation, hemostasis, and transfusion is essential in care of hemorrhagic shock. Although estimation of the residual blood volume is crucial, the standard measuring methods are impractical or unsafe. Vital signs, central venous or pulmonary artery pressures are inaccurate. We hypothesized that the residual blood volume for acute, non-ongoing hemorrhage was calculable using serial hematocrit measurements and the volume of isotonic solution infused. Blood volume is the sum of volumes of red blood cells and plasma. For acute, non-ongoing hemorrhage, red blood cell volume would not change. A certain portion of the isotonic fluid would increase plasma volume. Mathematically, we suggest that the residual blood volume after acute, non-ongoing hemorrhage might be calculated as 0·25N/[(Hct1/Hct2)-1], where Hct1 and Hct2 are the initial and subsequent hematocrits, respectively, and N is the volume of isotonic solution infused. In vivo validation and modification is needed before clinical application of this model.
液体复苏、止血和输血在失血性休克的治疗中至关重要。尽管估计残余血容量至关重要,但标准测量方法不切实际或不安全。生命体征、中心静脉压或肺动脉压并不准确。我们假设,对于急性、非持续性出血,可通过连续血细胞比容测量和输注的等渗溶液量来计算残余血容量。血容量是红细胞体积和血浆体积之和。对于急性、非持续性出血,红细胞体积不会改变。一定量的等渗液体会增加血浆体积。从数学角度来看,我们认为急性、非持续性出血后的残余血容量可计算为0·25N/[(Hct1/Hct2)-1],其中Hct1和Hct2分别为初始和随后的血细胞比容,N为输注的等渗溶液量。在该模型临床应用之前,需要进行体内验证和修正。